Physician profile
Jorge I Leiva
NPI 1538141247
$64,366.90
in general payments reported to CMS, 2019-2025
30 companies · $3,717 in 2025
The $3,717 reported for 2025 was more than what 88% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,390 · 2020: $9,520 · 2021: $8,948 · 2022: $11K · 2023: $20K · 2024: $5,720 · 2025: $3,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $20K · Food and Beverage: $4,823 · Travel and Lodging: $4,172 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,300.00 |
| Food and Beverage | $4,823.14 |
| Travel and Lodging | $4,171.72 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $53,094.91 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $2,829.43 | 2019-2023 | |
| Ethicon US, LLC | $2,505.33 | 2019-2024 | Echelon; Endopath, Linx Reflux Management System, Megadyne |
| Davol INC. | $2,025.37 | 2020-2025 | Phasix Mesh |
| Asensus Surgical, INC. | $1,193.19 | 2019 | |
| Medtronic, INC. | $581.45 | 2022-2025 | Ligasure, Manoscan, Signia |
| Covidien LP | $530.48 | 2019-2020 | |
| Tela Bio, INC. | $243.51 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Endogastric Solutions, INC | $200.67 | 2023-2024 | Esophyx |
| Smith+Nephew, INC. | $178.99 | 2025 | Stravix, Stravix Pl |
| Teleflex LLC | $178.76 | 2024 | Titan Sgs |
| Sanara Medtech INC. | $135.00 | 2021 | |
| Integra Lifesciences Corporation | $69.83 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Baxter Healthcare | $68.07 | 2022-2025 | Perclot |
| Novo Nordisk INC | $63.39 | 2019-2025 | Wegovy |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Standard Bariatrics, INC. | $58.00 | 2021 | |
| Innovation Technologies INC | $52.32 | 2024 | Irrisept |
| Kerecis Limited | $49.31 | 2020-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Abbott Laboratories | $44.14 | 2024-2025 | Proclaim |
| Endo Pharmaceuticals INC. | $42.81 | 2019-2020 | |
| Mimedx Group, INC. | $42.13 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.54 | 2020-2023 | Gattex |
| Kowa Pharmaceuticals America, INC. | $30.59 | 2023 | Seglentis |
| Ambu INC. | $24.46 | 2020 | |
| Misonix INC | $17.13 | 2020 | |
| Kci USA, INC. | $16.76 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Dilon Technologies, INC. | $16.59 | 2022 | |
| Innocoll Pharmaceuticals Limited | $16.07 | 2022 | |
| Organogenesis INC. | $15.85 | 2022 | |
| Bolder Surgical LLC | $6.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Leiva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.